Cargando…
Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients
Evidence for clinical screening and intervention for depression in cancer and the effect of this intervention on cancer prognosis is suboptimal. This study substantialized a complete model with universal screening and intervention for major depressive disorder (MDD) and explored its effect on surviv...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331985/ https://www.ncbi.nlm.nih.gov/pubmed/35893308 http://dx.doi.org/10.3390/jpm12081213 |
_version_ | 1784758537098887168 |
---|---|
author | Yen, Yung-Chieh Huang, Chin-Yu Chan, Hsue-Wei Wang, You-Yu Changchien, Te-Chang Wang, Deng-Wu Lin, Po-Chun Chang, Ting-Ting Chiu, Yu-Wen |
author_facet | Yen, Yung-Chieh Huang, Chin-Yu Chan, Hsue-Wei Wang, You-Yu Changchien, Te-Chang Wang, Deng-Wu Lin, Po-Chun Chang, Ting-Ting Chiu, Yu-Wen |
author_sort | Yen, Yung-Chieh |
collection | PubMed |
description | Evidence for clinical screening and intervention for depression in cancer and the effect of this intervention on cancer prognosis is suboptimal. This study substantialized a complete model with universal screening and intervention for major depressive disorder (MDD) and explored its effect on survival in patients. This longitudinal study recruited cancer patients routinely screened for MDD with a two-stage model. Data including sex, age, cancer diagnosis, first diagnosis date, date of death, cancer stage, and MDD diagnosis and treatment were collected from medical records and the national registration system for cancer. Kaplan–Meier’s survival analysis and the Cox proportional hazards regression model were applied to analyze the effects of associated factors on survival. Further subgroup analysis for 14 types of cancer primary site was also performed. Overall, the hazard for patients adhering to psychiatric treatment for MDD before cancer diagnosis was not statistically different from that for patients without MDD (hazard ratio (HR) = 1.061, 95% CI: 0.889–1.267, p = 0.512). The hazard for patients adhering to psychiatric treatment after cancer diagnosis was significantly lower than that for patients without MDD (HR = 0.702, 95% CI: 0.607–0.812, p < 0.001). Those who were diagnosed with MDD after cancer diagnosis and adhered poorly to psychiatric treatment had the greatest hazard (HR = 1.829, 95% CI: 1.687–1.984, p < 0.001). The effect of intervention for MDD varied across different primary cancer types. |
format | Online Article Text |
id | pubmed-9331985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93319852022-07-29 Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients Yen, Yung-Chieh Huang, Chin-Yu Chan, Hsue-Wei Wang, You-Yu Changchien, Te-Chang Wang, Deng-Wu Lin, Po-Chun Chang, Ting-Ting Chiu, Yu-Wen J Pers Med Article Evidence for clinical screening and intervention for depression in cancer and the effect of this intervention on cancer prognosis is suboptimal. This study substantialized a complete model with universal screening and intervention for major depressive disorder (MDD) and explored its effect on survival in patients. This longitudinal study recruited cancer patients routinely screened for MDD with a two-stage model. Data including sex, age, cancer diagnosis, first diagnosis date, date of death, cancer stage, and MDD diagnosis and treatment were collected from medical records and the national registration system for cancer. Kaplan–Meier’s survival analysis and the Cox proportional hazards regression model were applied to analyze the effects of associated factors on survival. Further subgroup analysis for 14 types of cancer primary site was also performed. Overall, the hazard for patients adhering to psychiatric treatment for MDD before cancer diagnosis was not statistically different from that for patients without MDD (hazard ratio (HR) = 1.061, 95% CI: 0.889–1.267, p = 0.512). The hazard for patients adhering to psychiatric treatment after cancer diagnosis was significantly lower than that for patients without MDD (HR = 0.702, 95% CI: 0.607–0.812, p < 0.001). Those who were diagnosed with MDD after cancer diagnosis and adhered poorly to psychiatric treatment had the greatest hazard (HR = 1.829, 95% CI: 1.687–1.984, p < 0.001). The effect of intervention for MDD varied across different primary cancer types. MDPI 2022-07-26 /pmc/articles/PMC9331985/ /pubmed/35893308 http://dx.doi.org/10.3390/jpm12081213 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yen, Yung-Chieh Huang, Chin-Yu Chan, Hsue-Wei Wang, You-Yu Changchien, Te-Chang Wang, Deng-Wu Lin, Po-Chun Chang, Ting-Ting Chiu, Yu-Wen Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients |
title | Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients |
title_full | Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients |
title_fullStr | Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients |
title_full_unstemmed | Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients |
title_short | Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients |
title_sort | longitudinal association of universal screening and treatment for major depressive disorder with survival in cancer patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331985/ https://www.ncbi.nlm.nih.gov/pubmed/35893308 http://dx.doi.org/10.3390/jpm12081213 |
work_keys_str_mv | AT yenyungchieh longitudinalassociationofuniversalscreeningandtreatmentformajordepressivedisorderwithsurvivalincancerpatients AT huangchinyu longitudinalassociationofuniversalscreeningandtreatmentformajordepressivedisorderwithsurvivalincancerpatients AT chanhsuewei longitudinalassociationofuniversalscreeningandtreatmentformajordepressivedisorderwithsurvivalincancerpatients AT wangyouyu longitudinalassociationofuniversalscreeningandtreatmentformajordepressivedisorderwithsurvivalincancerpatients AT changchientechang longitudinalassociationofuniversalscreeningandtreatmentformajordepressivedisorderwithsurvivalincancerpatients AT wangdengwu longitudinalassociationofuniversalscreeningandtreatmentformajordepressivedisorderwithsurvivalincancerpatients AT linpochun longitudinalassociationofuniversalscreeningandtreatmentformajordepressivedisorderwithsurvivalincancerpatients AT changtingting longitudinalassociationofuniversalscreeningandtreatmentformajordepressivedisorderwithsurvivalincancerpatients AT chiuyuwen longitudinalassociationofuniversalscreeningandtreatmentformajordepressivedisorderwithsurvivalincancerpatients |